The global viral vectors and plasmid dna manufacturing market was valued at $5.3 billion in 2023, and is projected to reach $34.0 Billion by 2033, growing at a CAGR of 20.4% from 2024 to 2033
The global hemophilia gene therapy market was valued at $0.4 billion in 2023, and is projected to reach $3.0 billion by 2033, growing at a CAGR of 23.6% from 2024 to 2033.
The global genu recurvatum market was valued at $6.5 billion in 2023, and is projected to reach $11.2 billion by 2033, growing at a CAGR of 5.6% from 2024 to 2033.
